Site Map

Antimitochondrial antibody

Antimitochondrial antibodies (AMA) are substances (antibodies) that form against mitochondria. The mitochondria are an important part of cells. They are the energy source inside the cells. These help the cells work properly.

This article discusses the blood test used to measure the amount of AMA in the blood.

Images

Blood test

I Would Like to Learn About:

How the Test is Performed

A blood sample is needed. It is most often taken from a vein. The procedure is called a venipuncture.

How to Prepare for the Test

Your health care provider may tell you not to eat or drink anything for up to 6 hours before the test (most often overnight).

How the Test will Feel

When the needle is inserted to draw blood, some people feel moderate pain. Others may feel only a prick or stinging sensation. Afterward, there may be some throbbing.

Why the Test is Performed

You may need this test if you have signs of liver damage. This test is most often used to diagnose primary biliary cholangitis, formerly called primary biliary cirrhosis (PBC).

The test may also be used to tell the difference between bile system-related cirrhosis and liver problems due to other causes such as a blockage, viral hepatitis, or alcoholic cirrhosis.

Normal Results

Normally, there are no antibodies present.

What Abnormal Results Mean

This test is important for diagnosing PBC. Almost all people with the condition will test positive. It is rare that a person without the condition will have a positive result. However, some people with a positive test for AMA and no other sign of liver disease may progress to PBC over time.

Rarely, abnormal results may also be found that are due to other kinds of liver disease and some autoimmune diseases.

Risks

Risks for having blood drawn are slight but can include:

Related Information

Antibody
Cirrhosis
Chronic
Hepatic
Bile
Hepatitis
Autoimmune hepatitis
Primary biliary cirrhosis
Rheumatoid arthritis
Systemic lupus erythematosus
Chronic thyroiditis (Hashimoto disease)

References

Beuers U, Gershwin ME, Gish RG, et al. Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'. Clin Res Hepatol Gastroenterol. 2015;39(5):e57-e59. PMID: 26433440 www.ncbi.nlm.nih.gov/pubmed/26433440.

Chernecky CC, Berger BJ. A. In: Chernecky CC, Berger BJ, eds. Laboratory Tests and Diagnostic Procedures. 6th ed. St Louis, MO: Elsevier Saunders; 2013:84-180.

Eaton JE, Lindor KD. Primary biliary cirrhosis. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management. 10th ed. Philadelphia, PA: Elsevier Saunders; 2016:chap 91.

Kakar S. Primary biliary cholangitis. In: Saxena R, ed. Practical Hepatic Pathology: A Diagnostic Approach. 2nd ed. Philadelphia, PA: Elsevier; 2018:chap 26.

Zhang J, Zhang W, Leung PS, et al. Ongoing activation of autoantigen-specific B cells in primary biliary cirrhosis. Hepatology. 2014;60(5):1708-1716. PMID: 25043065 www.ncbi.nlm.nih.gov/pubmed/25043065.

BACK TO TOP

Review Date: 1/10/2019  

Reviewed By: Gordon A. Starkebaum, MD, MACR, ABIM Board Certified in Rheumatology, Seattle, WA. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

ADAM Quality Logo

A.D.A.M., Inc. is accredited by URAC, for Health Content Provider (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics. This site complies with the HONcode standard for trustworthy health information: verify here.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2019 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

A.D.A.M. content is best viewed in IE9 or above, Firefox and Google Chrome browser.